Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ARS Pharmaceuticals (SPRY) Other Operating Expenses: 2024

Historic Other Operating Expenses for ARS Pharmaceuticals (SPRY) over the last 1 years, with Dec 2024 value amounting to $977,000.

  • ARS Pharmaceuticals' Other Operating Expenses rose 7213.39% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.1 million, marking a year-over-year change of. This contributed to the annual value of $977,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, ARS Pharmaceuticals' Other Operating Expenses is $977,000.
  • In the past 5 years, ARS Pharmaceuticals' Other Operating Expenses registered a high of $977,000 during FY2024, and its lowest value of $977,000 during FY2024.
  • Its 1-year average for Other Operating Expenses is $977,000, with a median of $977,000 in 2024.